Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis
Stolting, S., Klink, T., Bela, C., Engels, C., Wagner, T.
Int J Clin Pharmacol Ther. 2004 Nov;42(11):652-3.